Sunday, September 14th, 2025

GWM Accelerates Growth with Strong Sales of High-End EVs and New Model Launches

Date: 26 September 2024
Broker: UOB Kay Hian (Hong Kong) Limited


1. Company Overview

Great Wall Motors (GWM) (stock code: 2333 HK) is one of China’s largest automobile manufacturers, specializing in SUVs, trucks, and new energy vehicles (NEVs). GWM has increasingly focused on expanding its electric vehicle (EV) offerings to capture a larger share of the rapidly growing EV market.


2. Sales Performance (38th Week of 2024)

  • Wey Brand Performance: GWM’s Wey brand has risen to become one of the top 10 best-selling pure-play EV brands in the 38th week of 2024, recording 1,700 units sold.
  • Lanshan Model: Of the Wey brand’s total, 1,536 units were from the newly launched Lanshan model, which is equipped with advanced intelligent driving technology.

3. Product Innovation

GWM is focusing on high-end EV models, such as the Lanshan, to drive both sales growth and profitability. The new Lanshan model features CoffeePilot Ultra 3.0, an intelligent driving system that supports all-scenario navigation on autopilot (NOA) without the need for high-precision maps.


4. Financial Forecasts (2024-2026)

UOB Kay Hian forecasts continued growth for GWM over the next few years, driven by the launch of new high-end models:

  • 2024 Net Profit: RMB 15.17 billion
  • 2025 Net Profit: RMB 18.05 billion
  • 2026 Net Profit: RMB 20.63 billion

These profit estimates are based on expected sales volumes of 1.3 million units in 2024, 1.5 million units in 2025, and 1.7 million units in 2026.


5. Investment Outlook

GWM’s focus on launching innovative, high-end EV models positions it well for sales growth and margin expansion. With the successful rollout of the Lanshan model and the potential for new high-end models to optimize the product mix, GWM is set for strong financial performance in the coming years. UOB Kay Hian maintains a BUY rating for GWM with a target price of HK$20.00.

CIMB Group Positioned for Steady Growth with Attractive Valuation

Date: October 1, 2024Broker: UOB Kay Hian Sector Overview In the UOB Kay Hian report dated October 1, 2024, CIMB Group is highlighted as one of the top picks in the Malaysian banking sector....

Chularat Hospital: Poised for Strong 4Q24 with Higher Revenue per Adjusted RW

Date of Report: October 1, 2024Broker: CGS-CIMB Securities Malaysia Sdn. Bhd. Company Overview Chularat Hospital is a Thailand-based healthcare provider offering a wide range of medical services. The hospital group operates multiple facilities and...

Duopharma Biotech (DBB MK) Stock Analysis 2025: Strong Growth Outlook, Higher Target Price & Promising Financials

Broker: UOB Kay Hian Date of Report: 6 June 2025 Duopharma Biotech: Riding the Insulin Wave – Robust Growth, Margin Upside, and Strategic Resilience for 2025 Overview: Duopharma Biotech’s Promising Outlook for Investors Duopharma...